Prescription Drugs: . Describe and discuss the development of new drugs by the U.S. pharmaceutical industry.
The development of the new drugs by the U.S. pharmaceutical industry consist of the initial drug molecule/ drug entity development at the research and development end followed by various evaluation involving preclinical as well as clinical trials as per the cGLP guidelines and US- FDA guidelines.
The IND application is then made followed by the NDA application i.e. "new drug application for the approval of that new drug by the USFDA before its commercialization. Thus after NDA approval from the US-FDA the US pharmaceutical industry launches that drug in the market.
Prescription Drugs: . Describe and discuss the development of new drugs by the U.S. pharmaceutical industry.
Prescription Drugs: Describe and discuss the structure of the pharmaceutical industry.
Prescription Drugs: Describe and discuss the rationale for considering the pharmaceutical industry a public policy dilemma.
Prescription Drugs: Describe and discuss the main reasons for the ongoing increases in pharmaceutical expenditures in the United States.
The US pharmaceutical industry spent $6.4 billion on advertising prescription drugs directly to consumers in 2016. Since 1962 these ads have been regulated by the Food and Drug Administration (FDA) to ensure that they are not false or misleading. The United States and New Zealand are the only two countries where direct-to-consumer (DTC) advertising of prescription drugs is legal. Why should prescription drugs be advertised directly to consumers? Write at least five reasons.
Prescription Drugs: Describe and discuss the consequences of price controls on prescription drugs.
Prescription Drugs: Describe and discuss the political attractiveness of price controls on prescription drugs.
Prescription Drugs: Describe and discuss the history of prescription drug regulation.
Prescription Drugs: Describe and discuss why prescription drugs are expected to be priced lower overseas than US.
Prescription Drugs: Describe and discuss the rationale for FDA regulation of drugs.
Discuss the development of new drugs in the United States as compared to other countries, and evaluate the pharmacoeconomic issues that lead to high prescription costs in the United States.